Get started
Author

Nelvys Subirós

Observed names: N. Subiros, N. Subirós, Nelvys Subiros, Nelvys Subiros-Martinez, Nelvys Subirós Martínez, Nelvys Subirós-Martínez
ORCID: 0000-0002-4024-7759
Observed ORCID: 0000-0002-4024-7759
OpenAlex ID: A5038700899
Erythropoietin: still on the neuroprotection road
2012 · Nelvys Subirós, Diana García del Barco, et al. · Therapeutic Advances in Neurological Disorders · 48
PDF
Systemic and skin toxicity in cercopithecus aethiops sabaeus monkeys treated during 26 weeks with a high intravenous dose of the anti-epidermal growth factor receptor monoclonal antibody nimotuzumab
2007 · Maria Elene Arteaga, Nuris Nuris Ledon, et al. · Cancer Biology & Therapy · 34
PDF
Coadministration of epidermal growth factor and growth hormone releasing peptide-6 improves clinical recovery in experimental autoimmune encephalitis
2011 · Diana García del Barco, Enrique Montero, et al. · Restorative Neurology and Neuroscience · 19
Epidermal growth factor and growth hormone-releasing peptide-6: Combined therapeutic approach in experimental stroke
2013 · Diana García del Barco-Herrera, Nelvys Subirós Martínez, et al. · Restorative Neurology and Neuroscience · 14
Neuroprotective effect of epidermal growth factor plus growth hormone-releasing peptide-6 resembles hypothermia in experimental stroke
2016 · N. Subirós, H. Pérez-Saad, et al. · Neurological Research · 11
Neuroprotective effect of epidermal growth factor in experimental acrylamide neuropathy: an electrophysiological approach
2017 · H. Perez‐Saad, N. Subiros, et al. · Journal of the Peripheral Nervous System · 10
Assessment of dose–effect and therapeutic time window in preclinical studies of rhEGF and GHRP-6 coadministration for stroke therapy
2015 · Nelvys Subirós, Héctor M. Pérez-Saad, et al. · Neurological Research · 9
Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial
2024 · Francisco Hernández-Bernal, Donner Estenoz-García, et al. · Frontiers in Neurology · 7
PDF
“The impact of aging on cognitive and motor functions: a molecular and behavioral study in female C57BL/6 mice”
2025 · Daniela Risco-Acevedo, Nelvys Subirós-Martínez, et al. · Experimental Brain Research · 3
200 Repeated dose oral toxicity (13 weeks) of 4-hydroxy-3-methoxy-benzaldehyde (vanillin) to sprague dawley rats
2003 · Axel Mancebo, Yoagne M. Trapero, et al. · Toxicology Letters · 3
292 Acute and repeated dose intramuscular toxicity of N-acetilgm3 cancer vaccine in SD rats
2003 · A. Bada, A. Casacó, et al. · Toxicology Letters · 2
Detrimental impact of acute and chronic glucose burden in wound-healing cells: fibroblasts, myofibroblasts and vascular precursor cells
2012 · Jorge Berlanga-Acosta, Ernesto López-Mola, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Sensibilidad de los modelos de isquemia global y focal en el gerbil de Mongolia.
2005 · Iliana Sosa Testé, Jorge Daniel García Salmán, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke
2026 · Francisco Hernández-Bernal, Nelvys Subirós-Martínez, et al. · Journal of Clinical Neuroscience
EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences
2026 · Daniela Risco-Acevedo, Nelvys Subirós-Martínez, et al. · Neurotoxicity Research
A discovery-based proteomic approach of epidermal growth factor and growth hormone-releasing peptide-6 in a model of acute ischemic stroke
2026 · Arielis Rodríguez-Ulloa, Nelvys Subirós-Martínez, et al. · Pharmacological Reports
Toxicological evaluation in non human primates of the mAb h-R3 used in the treatment of the cancer
2008 · M.E. Arteaga, O. Hernández, et al. · European Journal of Cancer Supplements
Toxicological assessment of a N-GlicolilGM3 based-vaccine
2007 · Ana Bada, Angel Casacó, et al. · Toxicology Letters
Gangliosides-based cancer vaccines: Toxicological assays
2006 · A. Bada, A. Casacó, et al. · Toxicology Letters
Alternativa terapeutica en la isquemia cerebral empleando la Eritropoyetina humana recombinante (rHu-EPO CIM) como neuroprotector.
2005 · Iliana Sosa Testé, Jorge Daniel García Salmán, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
141 Toxicity assay to single dosis and to repeated dosis of humanized ACMT1HT by endovenous route in CENP:SPRD rats
2003 · Y. González, A. Casacó, et al. · Toxicology Letters
290 Anatomopathologic changes in sprague Dawley rats after 14 days repeated administration of human recombinant erythropoietin
2003 · D. Fuentes, M. Arteaga, et al. · Toxicology Letters
Works count: 22
Citation count: 162
H-index: 7
I10-index: 6
Year
Topic
Type